It is important to note that, in the other large type 2 diabetes cardiovascular outcome trials, there were no statistically significant associations with the use of GLP-1/GIP agonists and negative eye outcomes
Modern Applications of GLP-1 Moving Beyond Diabetes GLP-1 therapy options include new multi-target drugs incorporating GLP-1, GIP, and glucagon receptor signalling to provide weight reduction and glycemic regulation that mimic the outcomes achieved through surgery
Caring for your cellular health happens through consistent, thoughtful choices, and the results that endure come from working with your body's natural intelligence rather than trying to override it
Yes, THC in cannabis commonly increases appetite ("the munchies"), which may counteract tirzepatide's appetite-suppressing effects and lead to increased caloric intake, potentially compromising weight management goals
Increased BCAA levels also work in your favor by reducing the rate of protein breakdown